A real-world, retrospective, observational study examining treatment patterns and clinical outcomes in patients with FLT3m + AML in Japan
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A real-world, retrospective, observational study examining treatment patterns and clinical outcomes in patients with FLT3m + AML in Japan
Authors
Keywords
-
Journal
CURRENT MEDICAL RESEARCH AND OPINION
Volume -, Issue -, Pages 1-10
Publisher
Informa UK Limited
Online
2023-10-26
DOI
10.1080/03007995.2023.2271390
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overcoming Resistance: FLT3 Inhibitors Past, Present, Future and the Challenge of Cure
- (2022) Debora Capelli et al. Cancers
- Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia
- (2021) Naoko Hosono et al. International Journal of Clinical Oncology
- FLT3 Tyrosine Kinase Inhibitors for the Treatment of Fit and Unfit Patients with FLT3-Mutated AML: A Systematic Review
- (2021) Michael Loschi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- JSH Practical Guidelines for Hematological Malignancies, 2018: I. Leukemia-1. Acute myeloid leukemia (AML)
- (2020) Hitoshi Kiyoi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database
- (2020) Bhavik J. Pandya et al. Journal of Managed Care & Specialty Pharmacy
- A budget impact analysis of gilteritinib for the treatment of relapsed or refractory FLT3 mut+ acute myeloid leukemia in a US health plan
- (2020) Bhavik J. Pandya et al. JOURNAL OF MEDICAL ECONOMICS
- Targeting FLT3 mutations in AML: review of current knowledge and evidence
- (2019) Naval Daver et al. LEUKEMIA
- Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01
- (2019) Kenichi Miyamoto et al. International Journal of Clinical Oncology
- Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML
- (2019) Alexander E. Perl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment Strategies for Therapy-related Acute Myeloid Leukemia
- (2019) Prajwal Dhakal et al. Clinical Lymphoma Myeloma & Leukemia
- Precision therapy for acute myeloid leukemia
- (2018) Xue Yang et al. Journal of Hematology & Oncology
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Acute Myeloid Leukemia: A Concise Review
- (2016) Jennifer Saultz et al. Journal of Clinical Medicine
- Clinical studies of acute myeloid leukemia in the Japan Adult Leukemia Study Group
- (2012) Shuichi Miyawaki INTERNATIONAL JOURNAL OF HEMATOLOGY
- FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotype
- (2011) K. Wagner et al. HAEMATOLOGICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search